CN104258065A - 一种治疗哮喘的药物组合物 - Google Patents
一种治疗哮喘的药物组合物 Download PDFInfo
- Publication number
- CN104258065A CN104258065A CN201410576811.6A CN201410576811A CN104258065A CN 104258065 A CN104258065 A CN 104258065A CN 201410576811 A CN201410576811 A CN 201410576811A CN 104258065 A CN104258065 A CN 104258065A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- poria
- radix
- rhizoma
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 37
- 238000002360 preparation method Methods 0.000 claims abstract description 33
- 241000628997 Flos Species 0.000 claims abstract description 31
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 239000002552 dosage form Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 28
- 239000008194 pharmaceutical composition Substances 0.000 claims description 24
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 15
- 241000180649 Panax notoginseng Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000012467 final product Substances 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 238000004064 recycling Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003826 tablet Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 18
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000758794 Asarum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001454009 Gomphostemma Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 239000009759 San-Chi Substances 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 208000000059 Dyspnea Diseases 0.000 description 7
- 206010013975 Dyspnoeas Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000596154 Belamcanda Species 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011416 Croup infectious Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001552 airway epithelial cell Anatomy 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- -1 sublimed preparation Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药技术领域,具体涉及一种药物组合物及其制备方法和其在制备治疗哮喘中的用途。本发明所提供药物组合物,包含如下组分:茯苓、野菊花、白芥子、木锥花、三七、细辛、延胡索、藏红花、玉竹、款冬花、苍术、甘草。该药物组合物可以制备成药学上可以接受的药物剂型,制备工艺简单,并且该药物组合物在治疗哮喘方面均具有很好的效果,药物毒副作用小,用于临床推广有明显优势。
Description
技术领域
本发明属于医药技术领域,具体涉及一种治疗哮喘的药物组合物及其制备方法和其在治疗哮喘药物中的用途。
背景技术
支气管哮喘(bronchial asthma,简称哮喘,又称过敏性哮喘)是由多种细胞(嗜酸性粒细胞、肥大细胞、中性粒细胞、气道上皮细胞等)和细胞组份参与的气道慢性炎症性疾病,其可出现广泛可逆性气流受限,引起发作性的喘息、气急、胸闷,胸痛或咳嗽等临床症状。
支气管哮喘的发病基础是气道的非特异性炎症(包括体质和致病原两方面因素),发病的中心环节是支气管的反应性过高,而喘息发作的直接原因是支气管的痉挛,结果引起呼吸困难。它是一种严重威胁人类健康的慢性呼吸系统的疾病,各国患病率为1%-13%不等,我国的患病率为1%-4%,是常见病以及多发病。
近年来随着基础理论研究的不断深入,现代医学对于哮喘的治疗药物分主要分为三大类:抑制过敏介质释放药,消除非特异性炎症药和支气管舒张剂。临床上对于哮喘的治疗从以往的支气管扩张剂转变为抗气道炎症为主的药物治疗,糖皮质激素为抗气道炎症最主要的药物,这些药物只是能暂时改善哮喘症状,对哮喘患者长期使用会带来全身性副作用,吸入糖皮质激素对哮喘患者发作期症状虽有明显改善,但哮喘的发病率及死亡率并没有因此而减低,且远期疗效和预后评价也不甚满意,暴露出的各种弊端日益被临床医务工作者重视。哮喘严重危害着人们的身心健康,减弱劳动能力,降低生活质量,且易反复发作,难以得到根治。治疗哮喘的西药大多具有毒副作用,而中成药具有毒副作用小、疗效好的特点,受到广大患者的青睐,但是现代中医对哮喘的探讨还需要从发病机制、治疗方法、预防方法等方面进一步探讨,才会对哮喘这一常见症状和疾病有很好的治疗办法。
发明内容
本发明提供了一种治疗哮喘的药物组合物,该药物组合物疗效好,毒副作用小,它包含以下原料:茯苓、野菊花、白芥子、木锥花、三七、细辛、延胡索、藏红花、玉竹、款冬花、苍术、甘草。
在中医文献中,哮喘属于中医“喘鸣”、“哮吼”、呷嗽”等范畴。在有关中医书籍中关于哮喘病的论述始见于《黄帝内经》。《素问·玉机真脏论》有“秋脉……不及则令人喘,呼吸少气而喘。”《素问·逆调论》说:“夫不得卧……是水气之客也。”《素问·阴阳别论》:“起则熏肺,使人喘鸣。”《素问·痹论》说“肺痹者,烦满喘而呕。”再如《金匾要略·肺痰肺痈咳嗽上气病脉证并治》:“咳而上气,喉中水鸡声,射干麻黄汤主之。”《诸病源候论》称哮喘为“上气鸣息”、“呷嗽”。
本方中:茯苓,俗称云苓,其性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。野菊花,入肺、肝。疏风清热,消肿解毒。治肺炎、白喉,胃肠炎:高血压,疔,痈,口疮,丹毒,湿疹,天泡疮。白芥子,辛、温。入肺、肝、脾、胃、心包经。化痰逐饮;散结消肿。主咳喘痰多;胸满胁痛;肢体麻木;关节肿痛;湿痰流注;阴疽肿毒。木锥花,味苦、怀凉。清肺化痰;利尿通淋。主痰热咳喘;热淋;石淋;肾炎;水肿。三七,甘、微苦,温。归肝、胃经。功能与主治:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。细辛,辛、温。归心、肺、肾经。通窍止痛,温肺化饮。用于头痛,牙痛,鼻塞鼻渊,风湿痹痛,痰饮喘咳。延胡索,主治心腹腰膝诸痛;月经不调;症瘕;崩中;产后血晕;恶露不尽;跌打损伤。有镇痛、镇静、催眠作用。藏红花,甘,平。入心、肝经。活血化瘀,散郁开结。治忧思郁结,胸膈痞闷,吐血,伤寒发狂,惊怖恍惚,妇女经闭,产后瘀血腹痛,跌扑肿痛。玉竹,甘,微寒。归肺、胃经。养阴润燥,生津止渴。用于肺胃阴伤,燥热咳嗽,咽干口渴,内热消渴。款冬花,辛、微苦,温。归肺经。润肺下气,止咳化痰。用于新久咳嗽,喘咳痰多,劳嗽咳血。苍术具有燥湿健脾,祛风散寒,明目的功效,用于湿阻脾胃、脘腹胀满,寒湿白带,湿温病以及湿热下注、脚膝肿痛、痿软无力。治湿阻脾胃,而见脘腹胀满、食欲不振、倦怠乏力、舌苔白腻厚浊等症。甘草是一种补益中草药,具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
上述诸药配伍,可以相互作用、相互协同,共同作用起到温肺化饮、清热润燥之效能。本发明药物组合物还对上述诸味中药的重量份数进行了优选,优选的条件是中药配伍使用后药物对哮喘治疗效果的增强。优选的是,本发明药物组合物包含以下重量份的原料:茯苓10-18g、野菊花10-18g、白芥子8-16g、木锥花1-6g、三七10-15g、细辛5-12g、延胡索4-16g、藏红花2-7g、玉竹11-15g、款冬花2-5g、苍术5-9g、甘草11-22g。作为本发明的最优选实施例,本发明药物组合物包含以下重量份的原料:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
为了更好地表达本发明的药物组合物,本发明的药物组合物可以制备成临床上常用的剂型。比如,粉状制剂、散剂、丸剂、丹剂、膏剂、颗粒剂、口服液、糖浆、片剂、胶囊剂等制剂。优选地,本发明药物组合物按照常规制备工艺制备成口服液、颗粒剂、片剂或胶囊剂。
本发明还提供了一种上述所述药物组合物的制备方法,其主要包含下述步骤:取上述处方量的茯苓等十二味中药材加2-5倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为75-90%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术基础上加入适量辅料用常规制剂方法制成临床所能接受的各种剂型,即得。所述辅料为崩解剂、润滑剂、黏合剂等。
本发明还请求保护上述药物组合物在制备治疗哮喘药物中的用途。在通过急性毒性实验和长期毒性实验的安全性评价后,可知本发明药物组合物的毒副作用小、安全系数高。通过药效学实验可以确认本发明该药物组合物能明显改善大鼠的肺功能,具有显著的抗炎活性。在此基础上,本发明选取了医院的临床和门诊病历进行临床试验,共治疗哮喘患者155例,总有效率达100%。其中疗效标准包括以下四个方面:痊愈为临床症状体征消失,恢复正常;显效为临床症状体征基本或大部分消失;有效为临床症状明显好转,但需继续用药治疗;无效为临床症状体征无改善。服用方法:每天服用本发明药物组合物实施例1制备的片剂,每次1片,每日2次,早晚各一次,每片折生药约0.20g,连服30天,为1个疗程。针对155例患者,采用本发明的药物组合物进行了跟踪治疗,其中,治愈142例,显效8例,有效5例,无效0例,治愈率达到91.61%,总有效率为100%。治愈病例随访1年内无一例复发,显效和有效病例经过继续治疗均达到治愈效果。由此本发明药物组合物可有效缓解哮喘症状,推迟或减少哮喘复发。所以,本发明中药组合物对哮喘病预防和治疗有确切疗效,具有很好的临床意义,有显著的经济和社会效益。
本发明药物组合物为天然纯中药制剂,所选用的原料易得、配伍合理,制备工艺简单,不良反应和毒副作用显著降低,且本发明药物组合物作用全面,见效快,治愈率达到91.61%、总有效率达100%,药物治疗效果更佳,用药方便,显著提高了患者的用药依从性和生活质量,具有显著的临床推广价值。
具体实施方式
以下通过具体实施例进一步描述本发明,但是本发明不仅仅限于以下具体实施例。
实施例1
处方:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
制备工艺:
取上述处方量的茯苓等十二味中药材加3倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为80%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成片剂,即得。
实施例2
处方:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
制备工艺:
取上述处方量的茯苓等十二味中药材加4倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为85%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成胶囊剂,即得。
实施例3
处方:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
制备工艺:
取上述处方量的茯苓等十二味中药材加3倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为85%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成颗粒剂,即得。
实施例4
处方:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
制备工艺:
取上述处方量的茯苓等十二味中药材加4倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为80%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成散剂,即得。
实施例5
处方:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
制备工艺:
取上述处方量的茯苓等十二味中药材加2倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为75%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成口服液,即得。
实施例6
处方:茯苓10g、野菊花10g、白芥子8g、木锥花1g、三七10g、细辛5g、延胡索4g、藏红花2g、玉竹11g、款冬花2g、苍术5g、甘草11g。
制备工艺:
取上述处方量的茯苓等十二味中药材加5倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为90%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成颗粒剂,即得。
实施例7
处方:茯苓18g、野菊花18g、白芥子16g、木锥花6g、三七15g、细辛12g、延胡索16g、藏红花7g、玉竹15g、款冬花5g、苍术9g、甘草22g。
制备工艺:
取上述处方量的茯苓等十二味中药材加3倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为90%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成片剂,即得。
实施例8
处方:茯苓10g、野菊花18g、白芥子8g、木锥花6g、三七10g、细辛12g、延胡索4g、藏红花7g、玉竹11g、款冬花5g、苍术5g、甘草22g。
制备工艺:
取上述处方量的茯苓等十二味中药材加5倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为90%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成胶囊剂,即得。
实施例9
处方:茯苓18g、野菊花10g、白芥子16g、木锥花1g、三七15g、细辛5g、延胡索16g、藏红花2g、玉竹15g、款冬花2g、苍术9g、甘草11g。
制备工艺:
取上述处方量的茯苓等十二味中药材加2倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为75%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术上加入适量辅料用常规制剂方法制成片剂,即得。
Claims (5)
1.一种治疗哮喘的药物组合物,其特征在于,它包含以下重量份的原料:茯苓10-18g、野菊花10-18g、白芥子8-16g、木锥花1-6g、三七10-15g、细辛5-12g、延胡索4-16g、藏红花2-7g、玉竹11-15g、款冬花2-5g、苍术5-9g、甘草11-22g。
2.如权利要求1所述的药物组合物,其特征在于,它包含以下重量份的原料:茯苓14g、野菊花15g、白芥子12g、木锥花3g、三七12g、细辛8.5g、延胡索10g、藏红花4.5g、玉竹13g、款冬花3.5g、苍术7g、甘草17.5g。
3.如权利要求1、2所述的药物组合物,其特征在于,它是口服液、颗粒剂、片剂或胶囊剂。
4.一种如权利要求3所述的药物组合物的制备方法,其特征在于它包括以下步骤:取上述处方量的茯苓等十二味中药材加2-5倍水煎煮3.5小时,滤过,凉至室温后,加乙醇至浓度为75-90%,回流提取三次,回流时间为3h,滤过,滤液回收乙醇,浓缩至浸膏,干燥;本领域技术人员在该制备方法技术基础上加入适量辅料用常规制剂方法制成临床所能接受的各种剂型,即得。
5.如权利要求1、2所述的药物组合物在制备治疗哮喘药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410576811.6A CN104258065A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗哮喘的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410576811.6A CN104258065A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗哮喘的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104258065A true CN104258065A (zh) | 2015-01-07 |
Family
ID=52149722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410576811.6A Pending CN104258065A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗哮喘的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104258065A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102085301A (zh) * | 2011-01-02 | 2011-06-08 | 刘晓云 | 一种穴位治疗哮喘、慢性支气管炎、气管炎的中药组合物 |
CN103751505A (zh) * | 2013-12-30 | 2014-04-30 | 冯大祥 | 用于治疗哮喘的药酒 |
CN103784921A (zh) * | 2014-01-15 | 2014-05-14 | 纪晓青 | 一种治疗哮喘的中草药配方及其制备方法 |
-
2014
- 2014-10-24 CN CN201410576811.6A patent/CN104258065A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102085301A (zh) * | 2011-01-02 | 2011-06-08 | 刘晓云 | 一种穴位治疗哮喘、慢性支气管炎、气管炎的中药组合物 |
CN103751505A (zh) * | 2013-12-30 | 2014-04-30 | 冯大祥 | 用于治疗哮喘的药酒 |
CN103784921A (zh) * | 2014-01-15 | 2014-05-14 | 纪晓青 | 一种治疗哮喘的中草药配方及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN101983675A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN101041049A (zh) | 一种内服治疗慢性支气管炎的中药组合物 | |
CN103830636A (zh) | 一种治疗支气管炎哮喘的药物组合物 | |
CN104940485A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN101690787B (zh) | 治疗慢性胃炎、胃溃疡的中药 | |
CN102772650A (zh) | 治疗慢性咽炎的中药组合物及其制备方法 | |
CN102526236B (zh) | 一种治疗流行性感冒的药物及其制备方法 | |
CN101708286B (zh) | 治疗干燥综合症、顽固性口腔溃疡的中成药及其制法 | |
CN107737288A (zh) | 一种治疗过敏性哮喘的中药组合物及其制备方法 | |
CN103463517B (zh) | 治疗哮喘的药物 | |
CN102512575A (zh) | 治疗外感发热的中药 | |
CN105963501A (zh) | 一种制备治疗小儿哮喘的中药组合物的方法 | |
CN101647960B (zh) | 一种治疗咳嗽哮喘的中药 | |
CN105106710A (zh) | 医治哮喘的润肺化痰制剂的制备方法 | |
CN104258065A (zh) | 一种治疗哮喘的药物组合物 | |
CN116531457B (zh) | 一种治疗慢性咽炎病症的中药组合物及其应用 | |
CN106511812A (zh) | 一种治疗伤风感冒的药物及其制备方法 | |
CN105168860A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN106110156A (zh) | 一种用于慢性阻塞性肺疾病的膏方、制备方法及其用途 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN105456955A (zh) | 一种用于治疗抑郁症的药物制剂及其用途 | |
CN103623355B (zh) | 一种治疗滑动性斜疝的中药制剂 | |
CN103007076A (zh) | 一种治疗急性支气管炎的中药组合物 | |
CN116531457A (zh) | 一种治疗慢性咽炎病症的中药组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |
|
RJ01 | Rejection of invention patent application after publication |